Daicel Corporation

4202.T
Specialty Chemicals
2026/04/02 Updated
Market Cap: $2.0B (¥322.9B)
Stock Price: $7.90 (¥1,256)
Exchange Rate: 1 USD = ¥158.98

Notice Regarding the Status and Completion of Share Buyback (Share Buyback Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)

From March 1 to March 31, 2026, Daicel Corporation acquired 1,590,300 shares of treasury stock totaling ¥2,269,767,900 and completed the acquisition based on the Board of Directors resolution dated November 6, 2025.

Importance:
Page Updated: April 2, 2026
IR Disclosure Date: April 2, 2026

Key Figures

  • Total Number of Shares Acquired: 1,590,300 shares (March 1 to March 31, 2026)
  • Total Acquisition Cost: ¥2,269,767,900 (March 1 to March 31, 2026)
  • Cumulative Number of Shares Acquired: 10,094,500 shares (November 10, 2025 to March 31, 2026)

AI要約

Overview of Share Buyback

Daicel Corporation acquired 1,590,300 shares of treasury stock through market purchases on the Tokyo Stock Exchange from March 1 to March 31, 2026. The total acquisition cost amounted to ¥2,269,767,900. This acquisition was part of the share buyback authorized by the Board of Directors resolution on November 6, 2025, which set the maximum at 11 million shares, a maximum acquisition cost of ¥15 billion, and an acquisition period from November 10, 2025, to March 31, 2026.

Completion of Share Buyback and Cumulative Results

With this purchase, the share buyback based on the November 6, 2025 Board resolution has been completed. As of March 31, 2026, a total of 10,094,500 shares have been acquired at a cumulative cost of ¥13,753,036,850. The acquisition method was primarily market purchases on the Tokyo Stock Exchange, aiming to enhance capital efficiency as part of shareholder returns.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.